JCIA
RIGL icon

Jackson Creek Investment Advisors’s Rigel Pharmaceuticals RIGL Stock Holding History

Jackson Creek Investment Advisors’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-11,883
Closed -$321K – 402
2026
Q1 		$321K Sell
11,883
-11
-0.1% -$370 0.09% 278
2025
Q4 		$509K Sell
11,894
-169
-1% -$6.37K 0.15% 201
2025
Q3 		$342K Sell
12,063
-5,989
-33% -$179K 0.1% 253
2025
Q2 		$338K Sell
18,052
-19,993
-53% -$379K 0.09% 286
2025
Q1 		$684K Buy
+38,045
New +$772K 0.22% 208

Other funds holding RIGL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Soleus Capital Management
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Armistice Capital
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jackson Creek Investment Advisors's RIGL Position: Q2 2026 in Review

Jackson Creek Investment Advisors sold out of Rigel Pharmaceuticals (RIGL) in Q2 2026, closing a stake of 11,883 shares — an estimated $321K sold.

Jackson Creek Investment Advisors first reported a position in RIGL in Q1 2025 and held it in 5 quarters. The position peaked at $684K in Q1 2025. 155 funds tracked by Wall St. Rank hold RIGL as of Q2 2026.

  • Jackson Creek Investment Advisors reported no remaining Rigel Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Jackson Creek Investment Advisors sold 11,883 Rigel Pharmaceuticals shares in Q2 2026, an estimated $321K.
  • Jackson Creek Investment Advisors first reported a position in Rigel Pharmaceuticals in Q1 2025 and held it in 5 quarters.
  • Jackson Creek Investment Advisors's Rigel Pharmaceuticals position peaked at $684K in Q1 2025.
  • 155 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2026.

Based on Jackson Creek Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.